Best Peptides for Muscle Growth & Performance
The peptides most studied for muscle growth are growth-hormone secretagogues such as CJC-1295, ipamorelin, MK-677 (ibutamoren), sermorelin and tesamorelin, which stimulate the body’s own growth-hormone release. IGF-1 LR3 and follistatin are also researched for lean-mass pathways.
Most "muscle" peptides are growth-hormone secretagogues — they prompt the pituitary to release more of the body’s own growth hormone rather than supplying hormone directly. The classic research pairing is a GHRH analog (CJC-1295) with a ghrelin-mimetic (ipamorelin). Oral MK-677 works through a similar pathway. A separate group (IGF-1 LR3, follistatin, PEG-MGF) targets muscle-growth signaling more directly and carries higher uncertainty. Evidence quality varies widely — graded below.
⚠ Research & educational use only — not medical adviceMost-studied compounds for muscle growth & performance
Each links to a full research protocol with reconstitution steps, research dose ranges reported in the literature, and an honest evidence grade. Ranked roughly by depth of supporting research.
CJC-1295 + Ipamorelin
GH secretagogueThe most commonly studied research pairing — a GHRH analog plus a selective GH secretagogue, researched together for steadier GH release.
View protocol →Ipamorelin
GH secretagogueA selective GH secretagogue valued in research for stimulating GH with minimal effect on cortisol or appetite.
View protocol →CJC-1295 (no DAC)
GHRH analogA short-acting GHRH analog studied for pulsatile GH release, often paired with a secretagogue.
View protocol →MK-677
Oral secretagogueIbutamoren — an orally active GH secretagogue studied for sustained increases in GH and IGF-1.
View protocol →Tesamorelin
GHRH analogA GHRH analog with human data, studied for body-composition and visceral-fat outcomes.
View protocol →Sermorelin
GHRH analogOne of the earliest GHRH analogs, researched for GH stimulation with a long clinical history.
View protocol →IGF-1 LR3
IGF-1 analogA long-acting IGF-1 variant studied for direct muscle-growth signaling; potent and higher-risk in research models.
View protocol →Hexarelin
GH secretagogueA potent GH-releasing peptide studied for strong GH stimulation.
View protocol →Follistatin-344
Myostatin pathwayResearched for myostatin inhibition and muscle-mass pathways; largely preclinical.
View protocol →PEG-MGF
Repair factorA pegylated mechano-growth factor studied for muscle repair after mechanical stress.
View protocol →Sourcing these compounds for research
Researchers studying the molecules above source cGMP-tested material from our official sponsor, LiveWell Peptides. All compounds are sold strictly for laboratory research use.
Source at LiveWell Peptides →Preferred vendor. For research use only. Not for human consumption. Not medical advice.
Plan your research
Free tools to take any compound above from vial to a documented protocol.
Frequently asked questions
- Do muscle peptides work without training?
- In research models, growth-hormone secretagogues affect GH/IGF-1 signaling, but body-composition outcomes are studied in the context of training and nutrition. None are a substitute for resistance exercise.
- What is the most common beginner research pairing?
- CJC-1295 with ipamorelin is the most frequently studied combination because the two work on complementary pathways. See the dedicated protocol for dose ranges reported in the literature.
- Are these peptides legal and FDA-approved?
- Most research peptides discussed here are not FDA-approved for human use and are sold strictly for laboratory research purposes. A few molecules (such as certain GLP-1 receptor agonists) exist in approved prescription forms, but the research-grade material referenced on this site is not the same as a prescription product. Always consult a licensed healthcare provider before making any health decision.
- How strong is the research behind these?
- It varies by compound. Some — like the GLP-1 agonists — have large human clinical trials; others (such as BPC-157 or Epithalon) rest mainly on animal and in-vitro data with limited human studies. Each protocol page on this site grades the evidence so you can see exactly what is well-supported versus preliminary.